Testing for consistency in a single multicenter trial
- PMID: 1844692
- DOI: 10.1080/10543409108835006
Testing for consistency in a single multicenter trial
Abstract
One of the criteria for demonstrating efficacy in a single multicenter trial is that the centers are consistent with respect to the direction and significance of results. The purpose of this research is to discuss the use of the noncentrality parameter delta of an F distribution as a means of testing for the consistency of treatment effects across centers. We state the testing problem as H0: (delta > delta 0) versus H1: (delta < or = delta 0), where delta 0 is prespecified, so that H0 represents inconsistency and H1 consistency. Thus, strong evidence from the sample data is required in order to conclude that the treatment effects are consistent across centers. We discuss reasonable choices for delta 0 and develop the alpha-level, uniformly most powerful and unbiased test, which is equivalent to rejecting H0 if the 100(1 - alpha)% uniformly most accurate and unbiased upper confidence limit for delta is less than or equal to delta 0. We examine other tests based on upper confidence limits, such as those calculated from linear estimators of delta and those calculated from a likelihood approach. We investigate the performance of the tests in a small simulation study and present an example from a four-center clinical trial.
Similar articles
-
Demonstration of the reproducibility of treatment efficacy from a single multicenter trial.J Biopharm Stat. 1992;2(2):219-38. doi: 10.1080/10543409208835041. J Biopharm Stat. 1992. PMID: 1300215 Review.
-
Sample size calculation for multicenter randomized trial: taking the center effect into account.Contemp Clin Trials. 2007 Jul;28(4):451-8. doi: 10.1016/j.cct.2006.11.003. Epub 2006 Nov 17. Contemp Clin Trials. 2007. PMID: 17188941
-
Estimation of the treatment difference in multicenter trials.J Biopharm Stat. 2004 Nov;14(4):1037-63. doi: 10.1081/BIP-200035487. J Biopharm Stat. 2004. PMID: 15587979
-
Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.J Biopharm Stat. 2009 Sep;19(5):916-32. doi: 10.1080/10543400903105497. J Biopharm Stat. 2009. PMID: 20183452
-
Qualitative consistency of treatment effects in multiregional clinical trials.J Biopharm Stat. 2012 Sep;22(5):988-1000. doi: 10.1080/10543406.2012.703603. J Biopharm Stat. 2012. PMID: 22946945 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources